Response Biomedical Gets FDA OK for H1N1 Reactivity Info in Assay Package Insert | GenomeWeb

NEW YORK (GenomeWeb News) – Response Biomedical today said that the US Food and Drug Administration has granted a special 510(k) clearance to update the package insert on its RAMP Influenza A/B Assay Package Insert to include analytical reactivity information for the 2009 H1N1 flu virus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.